Rafferty Asset Management, LLC

Position in ARVN — Arvinas, Inc.

CIK 1389426 New York, NY

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$162,335

-$46,994 QoQ

Shares Held

19,535

+10.7% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#116

of 198 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. ARVN ranks #154 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$162,335	19,535	+10.7%	Shares	Sole	2026-08-14
2025-12-31	$209,329	17,650	+30.8%	Shares	Sole	2026-02-13
2025-09-30	$114,968	13,494	-46.3%	Shares	Sole	2025-11-12
2025-03-31	$176,272	25,110	+94.7%	Shares	Sole	2025-05-14
2024-09-30	$317,628	12,896	-1.4%	Shares	Sole	2024-11-13
2024-06-30	$348,136	13,078	+61.8%	Shares	Sole	2024-08-13
2024-03-31	$333,748	8,085	+64.6%	Shares	Sole	2024-05-13
2022-09-30	$218,490	4,911	-16.9%	Shares	Sole	2022-11-14
2022-06-30	$248,625	5,907	+18.2%	Shares	Sole	2022-08-12
2022-03-31	$336,298	4,997	-33.2%	Shares	Sole	2022-05-13
2021-12-31	$614,571	7,482	+8.0%	Shares	Sole	2022-02-10
2021-09-30	$569,260	6,927	+94.9%	Shares	Sole	2021-11-10
2021-06-30	$273,658	3,554	-28.6%	Shares	Sole	2021-08-10
2021-03-31	$328,979	4,977	-4.3%	Shares	Sole	2021-05-10
2020-12-31	$441,890	5,203	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.